This role provides medical and scientific leadership in the global development of new medicines for respiratory diseases and immunological disorders from Phase IIb to Phase IV.
Base: $241,613 – $362,420 USD; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program available; Benefits: 401(k) plan, paid vacation/holidays, leaves, medical/dental/vision coverage
Must-have
Nice-to-have
Not specified